"Neoadjuvant Immunotherapy Converts Hepatocellular Carcinoma (HCC) into Resectable Disease with Enhanced Antitumor Immunity"
Speaker: Mark Yarchoan, MD,
Department of Oncology
Division of Gastrointestinal Cancer
Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine
UCLA Jonsson Comprehensive Cancer Center -Signal Transduction and Therapeutics (STT) Program
For any questions regarding this event please contact: email@example.com